Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
North Chemical Industries Co., Ltd. (002246.SZ)
Luzhou, CN
North Chemical Industries Co., Ltd., based in Luzhou, People's Republic of China, specializes in the production and sale of nitrocellulose products across China. Its chemical offerings include various cellulose derivatives such as ethyl cellulose, hydroxyethyl cellulose, cellulose acetate butyrate, and carboxymethyl cellulose, alongside nitrocellulose chips. Additionally, the company supplies a range of industrial pumps, including desulphurization, slurry, general flow, magnetic, and axial flow models. These pumps find application in diverse sectors like chemical, fertilizer, metallurgy, mining, petrochemical, paper, pharmaceutical, sewage treatment, power plant desulfurization, and nuclear power industries. The company also maintains a significant international presence, exporting its products to approximately 20 countries and regions globally, notably the United States, Japan, Australia, France, Turkey, Iran, and Vietnam. Formerly, the company operated under the name Sichuan Nitrocell Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.18% | -6.07% | -9.48% | +1.98% | +24.17% | +20.31% | +82.65% | +139.29% | +212.39% | +53.54% | +368.25% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+41.3% ★ Q1'26: +17.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+1,100.0% ★ Q1'26: +142.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+8.2% ★ Q1'26: -26.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+11.3% ★ Q1'26: +16.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%+17.7% ★ Q1'26: +12.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-7.5% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.27× ★ Q1'26: 1.85× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
2.75B
est: 2.72B (+1.1%)
|
3.46B
3.46B – 3.46B
+27.2% YoY
|
4.28B
4.28B – 4.28B
+23.6% YoY
|
5.27B
5.27B – 5.27B
+23.2% YoY
|
| EBITDA |
418.92M
est: 230.55M (+81.7%)
|
293.34M
293.34M – 293.34M
+27.2% YoY
|
362.62M
362.62M – 362.62M
+23.6% YoY
|
446.68M
446.68M – 446.68M
+23.2% YoY
|
| EBIT |
310.74M
est: 111.25M (+179.3%)
|
141.55M
141.55M – 141.55M
+27.2% YoY
|
174.98M
174.98M – 174.98M
+23.6% YoY
|
215.55M
215.55M – 215.55M
+23.2% YoY
|
| Net Income |
263.02M
est: 240.89M (+9.2%)
|
340.39M
340.39M – 340.39M
+41.3% YoY
|
450.36M
450.36M – 450.36M
+32.3% YoY
|
581.28M
581.28M – 581.28M
+29.1% YoY
|
| SGA |
81.09M
est: 312.62M (-74.1%)
|
397.77M
397.77M – 397.77M
+27.2% YoY
|
491.72M
491.72M – 491.72M
+23.6% YoY
|
605.71M
605.71M – 605.71M
+23.2% YoY
|
| EPS |
0.50
est: 0.46 (+8.7%)
|
0.65
0.65 – 0.65
+41.3% YoY
|
0.86
0.86 – 0.86
+32.3% YoY
|
1.11
1.11 – 1.11
+29.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 146.4K | 0.39% |
| 2 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 95.9K | 0.29% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 40.6K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hecheng Yang | GM & Legal Representative | — | male |
| Hong Shang | Financial Director & Secretary of the Board of Directors | — | female |
| Hua Zhu | Deputy General Manager | — | male |
| Renxu Zhang | Chief Scientist | — | male |
| Weigang Zeng | Deputy General Manager | — | male |
| Weiwei Zhang | Deputy General Manager | — | female |
| Yongqiang Du | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002246.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
